Ariana Boswell

Ariana Boswell received her bachelor's degree in biochemistry from Vassar College and is currently pursuing her Master of Public Health in epidemiology at Columbia University Mailman School of Public Health. She has previously conducted research on rare and chronic diseases at Vassar College and Yale School of Medicine and hopes to remain involved in rare disease research and communications in the future. Ariana joined Rare Disease Advisor in 2024.

All articles by Ariana Boswell

What are mitochondria?

A single cell can contain hundreds or even thousands of mitochondria.
Clinical trial in Spain to evaluate doxecitin and doxribtimine in TK2d

A clinical trial in Spain aims to study the safety and efficacy of doxecitin and doxribtimine in adult patients with TK2d.
FDA approves first and only drug to treat TK2d

The FDA has approved Kygevvi™ (doxecitine and doxribtimine) for children and adults with Tk2d, making it the first treatment for the disease.
Planning for progressive mobility changes over time due to TK2d

From wheelchairs to walkers, mobility aids improve the accessibility of your surroundings.

Ariana Boswell

All articles by Ariana Boswell

What are mitochondria?

Clinical trial in Spain to evaluate doxecitin and doxribtimine in TK2d

FDA approves first and only drug to treat TK2d

Planning for progressive mobility changes over time due to TK2d